Furthermore, hormonal adaptations contribute significantly to plateaus
It targets GLP1, GIP, and glucagon receptors simultaneouslyhence the third generation label after single (Ozempic) and dual (Mounjaro) agonists
In the osteoarthritis trial, participants lost up to an average of 71.2 pounds with substantial relief from osteoarthritis pain
31,35-37 Prospective trials are needed to further explore this potential adverse event and worsened DR, which is the central premise of the ophthalmic FOCUS trial that is expected to release results in 2026
It was also discovered that using insulin to treat type-2 diabetes could lower this risk, but further research is still needed
5 Ways to Support Natural GLP-1 Production While medications provide a synthetic surge of GLP-1, your body is perfectly capable of producing its own through specific nutritional triggers